7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%
FLOWERS FOOD FLO
4.31%

Manulife Upgraded to Outperform

by Zacks Equity Research

October 10, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are upgrading our recommendation on the shares of shares of Manulife Financial Corp. ( MFC - Analyst Report ) to Outperform from Neutral following the recent announcement by the company to expand into Korea, which marks an expansion in its key Asian market. The company has also set up a head office in Cambodia. We believe further penetration in Asian markets will fuel long term earnings growth for the company.

Manulife is one of the dominant life insurers within its domestic Canadian market and possesses rapidly growing operations in the U.S. and several Asian countries. It has a diverse global presence with 75% of its earnings coming from outside Canada.

The company is doing business in the Asian market for over a century, which gives it a competitive advantage. Moreover, changing demographics has fueled demand for insurance and wealth management products in these regions and the company will likely benefit from this due to its longstanding presence.

Manulife is aligning its product offering to concentrate more on higher margin, low risk products as against higher risk-capital intensive products. Currently, 88% of its total premiums and deposits are in these targeted (lower-risk) products. Although this will result in subdued growth relative to its historical pace, we believe that it will deliver more sustainable growth targets and improve product margins as well as earnings consistency over time.

Manulife’s business exposes it to market volatility. However, the company is effectively building its hedging program to decrease both interest rate and equity market exposures. Manulife has, however, decreased its earnings sensitivity to both the above mentioned variables. It has reached its 2014 goal of offsetting interest rate sensitivity. The company now stands at 93% of its 2014 goal for equity market sensitivity. Manulife further plans to decrease these exposures.

Manulife retains a high quality investment portfolio. Its invested assets are highly diversified by sector and geography and have limited exposure to the high-risk areas. We continue to view the company’s investment management as a significant competitive advantage.

However, Manulife has been experiencing declining wealth sales in Canada as the competitive environment and continued low interest rate are adversely impacting investment product sales. We expect this line to remain under pressure in the near term given the current market scenario.

For the past several quarters the sharp decline in global equity markets, coupled with low bond yields, pressured the company’s capital position and the trend may continue in the near term as well.

Manulife currently retains a Zacks #1 Rank, which translates into a short-term Strong Buy rating. The company closely competes with China Life Insurance Co. Ltd. ( LFC - Analyst Report ) and Sun Life Financial Inc. ( SLF - Analyst Report ) .

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.